ArriVent BioPharma (AVBP) Preferred Shares Issued (2023)
ArriVent BioPharma's (AVBP) quarterly Preferred Shares Issued came in at -$24000.0 in Q2 2023, down 100.05% quarter-over-quarter from $44.9 million in Q1 2023.
ArriVent BioPharma (AVBP) Preferred Shares Issued (2023) Analysis & Trends
ArriVent BioPharma has disclosed Preferred Shares Issued across 1 years of filings, most recently posting -$24000.0 for Q2 2023.
- Preferred Shares Issued for Q2 2023 came in at -$24000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $44.9 million (changed N/A YoY), and the FY2023 annual result was $44.9 million, changed N/A from the prior year.
- Preferred Shares Issued came in at -$24000.0 for Q2 2023 at ArriVent BioPharma, down from $44.9 million in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $44.9 million in Q1 2023 to a low of -$24000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | ArriVent BioPharma | 1.37 Bn | 1.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -24,000.00 |
| Jun 30, 2023 | -24,000.00 |
| Mar 31, 2023 | 44.94 Mn |
| Mar 31, 2023 | 44.94 Mn |